Contribute Try STAT+ Today

As more federal and state lawmakers propose bills to allow Americans to import medicines from Canada, several Canadian organizations representing hospitals, pharmacies, distributors, physicians, and patients late last week asked the Canadian health ministry to ensure domestic supplies are not disrupted.

The missive was sent just as Sen. Bernie Sanders (I-Vt.) was set to take a highly publicized weekend trip to accompany a caravan of people with diabetes across the board to Canada to purchase lower-cost insulin. Such trips have generated growing publicity in the U.S., where the price of insulin has become a flashpoint in the wider debate over the cost of prescription medicines, in general.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • “Oh, Canada” – even more tensions with a good neighbor. There is the question of why, however. (The price difference, that is. . )

Comments are closed.